The biorenewable feedstock cardanol, a phenol compound substituted with an unsaturated C15 hydrocarbon chain, was selectively transformed into a cyclohexanone derivative through partial hydrogenation. Subsequent conversion via Baeyer-Villiger oxidation (BVO) gave a lactone product (pentadecylcaprolactone, PDCL), which is a mixture of two regioisomers. For the BVO, two variants that are based on either the direct use of a perbenzoic acid as reagent or alternatively the use of a readily available aldehyde in the presence of molecular oxygen as an attractive oxidation reagent have been studied and turned out to be feasible. In addition, suitable work-up has been demonstrated that furnished a sample of the cardanol-derived PDCL-type lactone in 84% isolated yield with 99% purity. Using metal-free polymerization techniques, a PDCL sample has then been readily converted into its homopolymer, which displays a low crystallinity, the latter due to moderate side-chain crystallization. Importantly, in a statistical copolymer with ε-caprolactone (CL), PDCL was shown to be a useful agent to modulate crystallinity, resulting in copolyesters with reduced or very minor crystallinity and accordingly low melting points. For such an effect, typically expensive and fossil-based monomers such as δ-valerolactone (VL) have to be used, highlighting the potential of PDCL for practical application.
No takes yet. Share an insight, caveat, or question.
Wohlfahrt et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: